February 18, 2019
INVITATION Patient Seminar: Minimal residual disease in Myeloma  with Prof. Nikhil C. Munshi on Sunday 31 March, from 4 – 5pm at North Shore Hospital Auditorium – Whenua Pupuke, Auckland RSVP to:  
Continue Reading
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Background Patients with multiple myeloma treated with lenalidomide maintenance therapy have improved progression-free survival, primarily following autologous stem-cell transplantation. A beneficial effect of lenalidomide maintenance therapy on overall survival in this setting has been inconsistent...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand